Affordable Access

Publisher Website

TGF-β Antisense Therapy Increases Angiogenic Potential in Human KeratinocytesIn Vitro∗

Archives of Medical Research
Publication Date
DOI: 10.1016/j.arcmed.2006.04.010
  • Keratinocytes
  • Chronic Wound
  • Vegf
  • Angiogenesis
  • Tgf-β
  • Biology
  • Chemistry
  • Medicine


Background Transforming growth factor-beta (TGF-β) has been identified as an important component of wound healing. Recent developments in molecular therapy offer exciting prospects for the modulation of wound healing, specifically those targeting TGF-β. The purpose of this study was to analyze the effect of TGF-β targeting on the expression of angiogenic vascular endothelial growth factor (VEGF), a key regulator of angiogenesis, and in vitro angiogenic activity. Methods Expression of angiogenic VEGF in tissue samples from chronic dermal wounds was investigated by immunohistochemistry. The effect of TGF-β targeting using antisense oligonucleotides on the expression of VEGF was analyzed by ELISA and RT-PCR in cultured human keratinocytes. Human endothelial cells (EC) were grown in conditioned medium produced from the treated keratinocytes. EC migration was measured using a modified Boyden chamber, EC tube formation was analyzed under the light microscope. Results Immunohistochemical investigation demonstrated a decreased expression of VEGF protein in tissue samples from chronic dermal wounds compared to normal human skin. Antisense TGF-β oligonucleotide treatment upregulated VEGF secretion in vitro. Addition of conditioned medium from TGF-β antisense-treated keratinocytes resulted in an increase of endothelial cell migration and tube formation. Conclusions Our results demonstrate that TGF-β antisense oligonucleotide technology may be a potential therapeutic option for stimulation of angiogenesis in chronic wounds.

There are no comments yet on this publication. Be the first to share your thoughts.


Seen <100 times

More articles like this

Tgf-beta antisense therapy increases angiogenic po...

on Archives of Medical Research January 2007

Targeted tumor therapy with the TGF-β2 antisense c...

on Cytokine & Growth Factor Revie... Jan 01, 2006

Abrogation of TGF-beta by antisense oligonucleotid...

on International Journal of Molec... October 2008

A potential pro-angiogenic cell therapy with human...

on Biochemical and Biophysical Re... Jan 01, 2004
More articles like this..